2 ms·
But the pharmaceutical companies have tried several times to get an Alzheimer's drug that work. Being the first one to get an approved drug is a license to prin
by jcranmer 5y ago
But the pharmaceutical companies have tried several times to get an Alzheimer's drug that work. Being the first one to get an approved drug is a license to print money to the tunes of tens or hundreds of billions of dollars--enough to cover the costs of development. The reason why we haven't had any yet is because they don't work.
Why should Biogen's probably-doesn't-work Alzheimer's drug get a pass that the dozen or more attempts that showed similarly bad results didn't get? Note in particular that the assessments of everyone who looked at Biogen's statistical claims here is that those claims are not substantiated by statistics.